Updated Jul 16, 2026
Sigal Charles Elliott has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | VIR | Vir Biotechnology, Inc. | A — Grant or award | 8.0K | $0.00 | |
| 2026-05-22 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | A — Grant or award | 671 | $0.00 | |
| 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | A — Grant or award | 775 | $0.00 |
Sigal Charles Elliott is a corporate insider — currently tracked as Director of Vir Biotechnology, Inc. (VIR). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sigal Charles Elliott profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.